Prediction of the PRONOUNCE Prostate Cancer Trial in Healthcare Claims Data

NCT04897958 · clinicaltrials.gov ↗

COMPLETED

Status

14417

Enrollment

OTHER

Sponsor class

Conditions

Prostate Cancer

Interventions

DRUG: Degarelix
DRUG: Leuprolide

Sponsor

Brigham and Women's Hospital